Thursday, September 15, 2016

Feds To Spend $4.6 Million To Give 'Emotional Wellness' To Refugees

When’s the government going to look out for our emotional wellness? [Ed: the Govt already IS, God damn the bought and paid for scumbags.] 
We’ve suffered from 8 years of the most deteriorating regime in history.
The Obama administration plans to spend $4.6 million next year on health promotion and “emotional wellness” for refugees as President Obama plans a 30 percent increase in the number of refugees admitted into the country.
The Department of Health and Human Services issued a grant forecast last month detailing its plans to issue health care grants for refugees on top of government programs that are already available, such as Medicaid.
“The Office of Refugee Resettlement (ORR) within the Administration for Children and Families (ACF) invites States to submit applications for Refugee Health Promotion (RHP) discretionary grant funds,” the grant forecast says. “The purpose of the RHP grant is to support health and emotional wellness among refugees. The program is designed to coordinate and promote local health and mental health services and education.”

Thank You Nick and Free Beacon. 

FDA Reveals User Fee Rates For 2016

Prescription Drug User Fee Act (PDUFA)201620152014
New Drug Application (With Clinical Data)
$2,374,200$2,335,200$2,169,100New Drug Application (Without Clinical Data)$1,187,100$1,167,600$1,084,550New Drug Application Supplement With Clinical Data$1,187,100$1,167,600$1,084,550 - See more at:

Does that sound like a lot of money?

Johnson & Johnson Buys Pfizer Consumer Unit For $16.6 BILLION

To Pharma it's pocket change.

Ask yourself Who the FDA's real customers are, and where FDA's real loyalties lie.

And what has the public got out of it?

wiki on JNJ

Illegal marketing of Risperdal[edit]

Juries in several US states have found J&J guilty of concealing the adverse effects of Janssen Pharmaceuticalsantipsychoticmedication Risperdal, produced by its unit, in order to promote it to doctors and patients as better than cheaper generics, and of falsely marketing it for treating patients with dementia.[66] States that have awarded damages include Texas ($158 million), South Carolina ($327 million), Louisiana ($258 million), and most notably Arkansas ($1.2 billion).[67]
In 2010, the United States Department of Justice joined a whistleblowers suit accusing the company of illegally marketing Risperdal through Omnicare, the largest company supplying pharmaceuticals to nursing homes.[68][69] The allegations include that J&J were warned by the U.S. Food and Drug Administration (FDA) not to promote Risperdal as effective and safe for elderly patients, but they did so, and that they paid Omnicare to promote the drug to care home physicians.[70] The settlement was finalized on November 4, 2013, with J&J agreeing to pay a penalty of around $2.2 billion, "including criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion."[71]

Johnson & Johnson has also been subject to congressional investigations related to payments given to psychiatrists to promote its products and ghost write articles, notably Joseph Biederman and his pediatric bipolar disorder research unit.[72]

No comments: